Education
About Us
Working with TipRanks
Follow Us
Legend Biotech Corporation (LEGN)
NASDAQ:LEGN
Earnings Data
Report Date
Mar 18, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.01Last Year’s EPS
0.07Same Quarter Last Year
Strong Buy
Based on 9 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflects a largely positive outlook driven by significant sales growth of CARVYKTI, successful international expansion, and advancements in clinical trials and manufacturing capacity. However, challenges like managing neurotoxicity and achieving profitability remain.Company Guidance
Significant Increase in CARVYKTI Sales
CARVYKTI net trade sales were approximately $524 million, marking an 84% increase year-over-year, with a CAGR of 111% since launch.
Record Patient Treatment
Over 9,000 patients have been treated with CARVYKTI, showcasing robust adoption and the strongest CAR-T launch to date.
Expansion in International Markets
Strong sales growth outside the U.S. with an increase of nearly 5x compared to the same period last year, driven by launches in Germany, Spain, and Belgium.
Progress in Manufacturing Capacity
Tech Lane facility initiated commercial production, supporting increased demand in Europe, and expansion at Raritan facility in the U.S. is on track.
Advancements in Clinical Trials
Initiation of CARTITUDE-10 Phase II trial and expected completion of enrollment for CARTITUDE-5 and 6 by year-end, aiming to move CARVYKTI into the frontline setting.
LEGN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
LEGN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 12, 2025 | $32.03 | $31.18 | -2.65% |
Aug 11, 2025 | $37.00 | $36.24 | -2.05% |
May 13, 2025 | $32.38 | $31.08 | -4.01% |
Mar 11, 2025 | $34.03 | $37.19 | +9.29% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Legend Biotech Corporation (LEGN) report earnings?
Legend Biotech Corporation (LEGN) is schdueled to report earning on Mar 18, 2026, After Close (Confirmed).
What is Legend Biotech Corporation (LEGN) earnings time?
Legend Biotech Corporation (LEGN) earnings time is at Mar 18, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is LEGN EPS forecast?
LEGN EPS forecast for the fiscal quarter 2025 (Q4) is -0.01.